Acute Myeloid Leukemia (Relapsed/Refractory)
2 clinical trials · Condition
◉ Watch Acute Myeloid Leukemia (Relapsed/Refractory)
| Record | Firm | Date |
|---|---|---|
| Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients (NCT05951855) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT02249091) | GSO Global Clinical Research BV | 2014-09-01 |
Track Acute Myeloid Leukemia (Relapsed/Refractory) automatically
Every clearance here is in the API, with alerts when new ones post.